secwatch.observer — SEC 8-K summary
======================================

Issuer:     Revolution Medicines, Inc. (RVMD)
CIK:        0001628171
Form:       8-K
Filed at:   2023-03-07T23:59:59+00:00
Accession:  0001193125-23-062952
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revolution Medicines closes public offering of 15.7M shares for $323.6M net proceeds
--------------------------------------------------------------------------------

- Offering of 15,681,818 shares of common stock at $22.00 per share to the public.
- Underwriters purchased at $20.68 per share; net proceeds of approx. $323.6M.
- Full exercise of underwriters' option; 30-day option period for additional 2M shares.
- Company and insiders subject to 60-day lock-up from prospectus date.
- Lead underwriters: J.P. Morgan, Cowen, SVB Securities, Guggenheim Securities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628171/000119312523062952/0001193125-23-062952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628171/000119312523062952/d473040d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-062952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer